Article
Peginterferon and ribavirin in HCV: improvement of sustained viral response.
Best practice & research. Clinical gastroenterology - 1 Jan 2008
Ferenci P
Abstract excerpt
Peginterferon alfa in combination with ribavirin is and will remain for the next years the current standard for treatment of chronic hepatitis C. The new antivirals currently investigated in phase II of III trials may augment the overall response rates but require peginterferon/ribavirin as backbone. The cure rate of peginterferon/ribavirin treatment can be improved by better education of treating physicians to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
